Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgina Arrambide

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Continuum (Minneapolis, Minn.)|April 2, 2026
Diagnosis of Multiple SclerosisGeorgina Arrambide, Christine Lebrun-Frénay
Journal of the Neurological Sciences|June 3, 2014
Predictive markers of disease evolution after a CIS in everyday practiceGeorgina Arrambide, Jaume Sastre-Garriga
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 17, 2019
Oligoclonal bands do not represent dissemination in time in the 2017 revisions to the McDonald criteriaGeorgina Arrambide, Mar Tintore, Xavier Montalban
Frontiers in Immunology|November 4, 2024
Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosisGeorgina Arrambide, Manuel Comabella, Carmen Tur
Nature Reviews. Neurology|September 17, 2025
A paradigm shift away from dissemination in time in multiple sclerosisAgustín Pappolla, Georgina Arrambide, Xavier Montalban
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2015
Comment on severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibodyGeorgina Arrambide, Carmen Tur, Xavier Montalban
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 6, 2015
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level-NOGeorgina Arrambide, Carmen Espejo, Mar Tintore
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 26, 2011
A prospective series of patients with hyperglycaemia-associated movement disordersAmin Cervantes-Arriaga, Georgina Arrambide, Mayela Rodríguez-Violante
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 28, 2014
NMO spectrum disorders: how wide is the spectrum?Georgina Arrambide, Alex Rovira, Carmen Tur, et al.
The Lancet. Neurology|May 25, 2019
Introducing the International Women in Multiple Sclerosis networkVilija G Jokubaitis, Anne-Katrin Pröbstel, Georgina Arrambide, et al.
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Continuum (Minneapolis, Minn.)|April 2, 2026
Diagnosis of Multiple SclerosisGeorgina Arrambide, Christine Lebrun-Frénay
Journal of the Neurological Sciences|June 3, 2014
Predictive markers of disease evolution after a CIS in everyday practiceGeorgina Arrambide, Jaume Sastre-Garriga
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 17, 2019
Oligoclonal bands do not represent dissemination in time in the 2017 revisions to the McDonald criteriaGeorgina Arrambide, Mar Tintore, Xavier Montalban
Frontiers in Immunology|November 4, 2024
Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosisGeorgina Arrambide, Manuel Comabella, Carmen Tur
Nature Reviews. Neurology|September 17, 2025
A paradigm shift away from dissemination in time in multiple sclerosisAgustín Pappolla, Georgina Arrambide, Xavier Montalban
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2015
Comment on severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibodyGeorgina Arrambide, Carmen Tur, Xavier Montalban
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 6, 2015
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level-NOGeorgina Arrambide, Carmen Espejo, Mar Tintore
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 26, 2011
A prospective series of patients with hyperglycaemia-associated movement disordersAmin Cervantes-Arriaga, Georgina Arrambide, Mayela Rodríguez-Violante
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 28, 2014
NMO spectrum disorders: how wide is the spectrum?Georgina Arrambide, Alex Rovira, Carmen Tur, et al.
The Lancet. Neurology|May 25, 2019
Introducing the International Women in Multiple Sclerosis networkVilija G Jokubaitis, Anne-Katrin Pröbstel, Georgina Arrambide, et al.
Pageof 12